Clinical Trials

98 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT05328505 2026-03-24

MIDAS-Prostate

80 enrolled

Adenocarcinoma, Prostatic Neoplasms, Recurrence

NCT03493425 2026-03-23

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

82 enrolled

Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7

NCT07348887 2026-03-04

RTL-DART

50 enrolled

Head & Neck

Squamous Cell Cancer of Head and Neck (SCCHN)

NCT04983095 2026-02-17

METRO

118 enrolled

Prostate Cancer Metastatic

NCT06547398 2026-02-05

Prostate Adaptive Radiation Therapy

130 enrolled

Prostatic Neoplasms

NCT06650033 2026-02-05

Pelvis ART

280 enrolled

Gynecologic

Pelvic Neoplasms

NCT06378866 2025-12-26

DIVINE

532 enrolled

Prostatic Neoplasms

NCT06499870 2025-10-21

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

50 enrolled

Prostate Adenocarcinoma

NCT06549478 2025-09-17

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

Phase 1 Recruiting

24 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06546267 2025-06-11

PROST-ART

Recruiting

2,500 enrolled

Lymphatic Metastasis, Prostatic Neoplasms

NCT06306170 2025-04-22

GYN-ART

Recruiting

1,000 enrolled

Radiation Injuries, Disease Progression

NCT06216171 2024-09-27

ProHEART

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06330909 2024-03-26

HypoF-SBRT

374 enrolled